AZBigMedia reports that Sinfonía HealthCare Corporation's sale of subsidiary and UA startup SinfoníaRx to Tabula Rasa Healthcare, Inc. has been selected as the 2017 Deal of the Year by the Arizona chapter of the Association for Corporate Growth.

Iluminos Therapeutics has licensed UA-created compounds that have the potential to treat neurodegenerative disease. The inventors hail from the Department of Pharmacology and Toxicology and the ASU-Banner Neurodegenerative Disease Research Center.

UA researchers Drs. Bhaskar Banerjee and Rongguang “Ron” Liang have invented a dual-view probe for medical endoscopy demonstrated to increase polyp detection rates 58 percent to 98 percent. Their startup, Omniscient, is working to bring the technology to the public.

On March 19, TLA held its fifth annual I-Squared Expo & Awards, honoring those whose work impacts the quality of life for people in Tucson, across Arizona and throughout the world through research, invention, collaboration and commercialization.

The UA has named Douglas Hockstad to fill the position held by David Allen, effective April 28, 2018. Allen, who is retiring, was appointed as TLA vice president in 2012 to reinvigorate the UA’s research commercialization activities.

A team of researchers at the UA College of Optical Sciences have invented a new breed of spectrometer capable of rapidly analyzing the chemical makeup of materials. Their first target market? Natural products and pharmaceuticals, including cannabis.